Chemfab Alkalis Crecimiento futuro

Future controles de criterios 0/6

Actualmente no disponemos de suficiente cobertura de analistas para prever el crecimiento y los ingresos de Chemfab Alkalis.

Información clave

n/a

Tasa de crecimiento de los beneficios

n/a

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Chemicals	20.6%
Tasa de crecimiento de los ingresos	n/a
Rentabilidad financiera futura	n/a
Cobertura de analistas	None
Última actualización	n/a

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Here's What's Concerning About Chemfab Alkalis' (NSE:CHEMFAB) Returns On Capital

Apr 04

Market Might Still Lack Some Conviction On Chemfab Alkalis Limited (NSE:CHEMFAB) Even After 30% Share Price Boost

Feb 23

Some Investors May Be Worried About Chemfab Alkalis' (NSE:CHEMFAB) Returns On Capital

Feb 02

Does Chemfab Alkalis (NSE:CHEMFAB) Have A Healthy Balance Sheet?

Dec 20

Returns On Capital Are Showing Encouraging Signs At Chemfab Alkalis (NSE:CHEMFAB)

Sep 27

Increases to CEO Compensation Might Be Put On Hold For Now at Chemfab Alkalis Limited (NSE:CHEMFAB)

Jul 28

Chemfab Alkalis (NSE:CHEMFAB) Is Doing The Right Things To Multiply Its Share Price

Jun 11

Could Chemfab Alkalis Limited (NSE:CHEMFAB) Have The Makings Of Another Dividend Aristocrat?

Apr 19

Is Chemfab Alkalis (NSE:CHEMFAB) Likely To Turn Things Around?

Feb 25

Chemfab Alkalis (NSE:CHEMFAB) Has A Somewhat Strained Balance Sheet

Jan 18

Three Things You Should Check Before Buying Chemfab Alkalis Limited (NSE:CHEMFAB) For Its Dividend

Dec 23

What Do The Returns On Capital At Chemfab Alkalis (NSE:CHEMFAB) Tell Us?

Nov 27

Are Chemfab Alkalis's (NSE:CHEMFAB) Statutory Earnings A Good Guide To Its Underlying Profitability?

Nov 01

We Think Chemfab Alkalis (NSE:CHEMFAB) Is Taking Some Risk With Its Debt

Sep 09

Here’s What’s Happening With Returns At Chemfab Alkalis (NSE:CHEMFAB)

Aug 03

Is Chemfab Alkalis Limited (NSE:CHEMFAB) A Good Fit For Your Dividend Portfolio?

Jul 07

En esta sección solemos presentar previsiones de crecimiento de ingresos y beneficios basadas en las estimaciones por consenso de analistas profesionales para ayudar a los inversores a comprender la capacidad de la empresa para generar beneficios. Pero como Chemfab Alkalis no ha proporcionado suficientes datos anteriores y no dispone de previsiones de analistas, sus beneficios futuros no pueden calcularse de forma fiable extrapolando datos anteriores o utilizando las previsiones de los analistas.

Es una situación poco común, ya que el 97% de las empresas disponibles en SimplyWall St sí disponen de datos financieros anteriores.

Previsiones de crecimiento de beneficios e ingresos

NSEI:CHEMFAB - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2023	3,183	362	N/A	N/A	N/A
9/30/2023	3,159	440	118	694	N/A
6/30/2023	3,123	527	N/A	N/A	N/A
3/31/2023	3,314	646	350	926	N/A
12/31/2022	3,462	621	N/A	N/A	N/A
9/30/2022	3,400	592	606	808	N/A
6/30/2022	3,227	470	N/A	N/A	N/A
3/31/2022	2,716	287	347	549	N/A
12/31/2021	2,349	43	N/A	N/A	N/A
9/30/2021	2,034	-66	340	413	N/A
6/30/2021	1,875	-67	N/A	N/A	N/A
3/31/2021	1,808	-81	381	454	N/A
12/31/2020	1,702	53	N/A	N/A	N/A
9/30/2020	1,753	96	-199	424	N/A
6/30/2020	1,889	181	N/A	N/A	N/A
3/31/2020	2,045	254	-80	542	N/A
12/31/2019	2,201	326	N/A	N/A	N/A
9/30/2019	2,126	336	36	567	N/A
6/30/2019	1,999	174	N/A	N/A	N/A
3/31/2019	1,932	168	-120	410	N/A
12/31/2018	1,877	156	N/A	N/A	N/A
9/30/2018	1,892	162	N/A	N/A	N/A
6/30/2018	1,902	296	N/A	N/A	N/A
3/31/2018	1,796	255	177	439	N/A
3/31/2017	1,402	155	N/A	379	N/A
3/31/2016	248	4	N/A	-7	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Datos insuficientes para determinar si el crecimiento previsto de los beneficios de CHEMFAB es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Datos insuficientes para determinar si se prevé que los beneficios de CHEMFAB crezcan más rápidamente que el mercado Indian

Beneficios de alto crecimiento: Datos insuficientes para determinar si se espera que los beneficios de CHEMFAB crezcan significativamente en los próximos 3 años.

Ingresos vs. Mercado: No hay datos suficientes para determinar si se prevé que los ingresos de CHEMFAB crezcan más rápidamente que el mercado de Indian.

Ingresos de alto crecimiento: No hay datos suficientes para determinar si se prevé que los ingresos de CHEMFAB crezcan a un ritmo superior a 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de CHEMFAB se prevé que sea elevada dentro de 3 años.

Chemfab Alkalis Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Here's What's Concerning About Chemfab Alkalis' (NSE:CHEMFAB) Returns On Capital

Investor sentiment improves as stock rises 26%

Investor sentiment improves as stock rises 34%

Now 31% overvalued after recent price rise

Market Might Still Lack Some Conviction On Chemfab Alkalis Limited (NSE:CHEMFAB) Even After 30% Share Price Boost

New minor risk - Share price stability

Third quarter 2024 earnings released: EPS: ₹5.00 (vs ₹10.56 in 3Q 2023)

Second quarter 2024 earnings released: EPS: ₹3.03 (vs ₹9.22 in 2Q 2023)

Chemfab Alkalis Limited to Report Q2, 2024 Results on Oct 26, 2023

Upcoming dividend of ₹1.25 per share at 0.4% yield

Chemfab Alkalis Limited to Report Q3, 2024 Results on Feb 14, 2024

First quarter 2024 earnings released: EPS: ₹6.70 (vs ₹15.10 in 1Q 2023)

Chemfab Alkalis Limited to Report Q1, 2024 Results on Jul 27, 2023

Do Chemfab Alkalis' (NSE:CHEMFAB) Earnings Warrant Your Attention?

Investor sentiment improves as stock rises 16%

Full year 2023 earnings released: EPS: ₹45.61 (vs ₹20.36 in FY 2022)

Chemfab Alkalis Limited Recommends Final Dividend

Now 20% undervalued

Now 21% undervalued

Investor sentiment improves as stock rises 26%

Chief Executive Officer recently sold ₹5.8m worth of stock

Now 20% undervalued after recent price drop

Under The Bonnet, Chemfab Alkalis' (NSE:CHEMFAB) Returns Look Impressive

Third quarter 2023 earnings released: EPS: ₹10.56 (vs ₹8.56 in 3Q 2022)

Chemfab Alkalis Limited to Report Q3, 2023 Results on Feb 07, 2023

Investor sentiment deteriorated over the past week

Insufficient new directors

Second quarter 2023 earnings released: EPS: ₹9.22 (vs ₹0.58 in 2Q 2022)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Upcoming dividend of ₹1.25 per share

Why We Like The Returns At Chemfab Alkalis (NSE:CHEMFAB)

Chemfab Alkalis Limited to Report Q4, 2023 Results on May 30, 2023

Investor sentiment improved over the past week

Chemfab Alkalis Limited, Annual General Meeting, Sep 15, 2022

Investor sentiment improved over the past week

Insufficient new directors

First quarter 2023 earnings released: EPS: ₹15.10 (vs ₹2.18 in 1Q 2022)

Chemfab Alkalis Limited to Report Q1, 2023 Results on Jul 27, 2022

Insufficient new directors

Full year 2022 earnings released: EPS: ₹2.53 (vs ₹5.81 loss in FY 2021)

Chemfab Alkalis Limited Recommends Final Dividend

Chemfab Alkalis Limited to Report Q4, 2022 Results on May 25, 2022

Be Wary Of Chemfab Alkalis (NSE:CHEMFAB) And Its Returns On Capital

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Chemfab Alkalis Limited Announces Management Changes

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Some Investors May Be Worried About Chemfab Alkalis' (NSE:CHEMFAB) Returns On Capital

Does Chemfab Alkalis (NSE:CHEMFAB) Have A Healthy Balance Sheet?

Returns On Capital Are Showing Encouraging Signs At Chemfab Alkalis (NSE:CHEMFAB)

Increases to CEO Compensation Might Be Put On Hold For Now at Chemfab Alkalis Limited (NSE:CHEMFAB)

Full year 2021 earnings released: ₹5.81 loss per share (vs ₹18.27 profit in FY 2020)

Chemfab Alkalis (NSE:CHEMFAB) Is Doing The Right Things To Multiply Its Share Price

Full year 2021 earnings released: ₹5.81 loss per share (vs ₹18.27 profit in FY 2020)

Investor sentiment improved over the past week

Could Chemfab Alkalis Limited (NSE:CHEMFAB) Have The Makings Of Another Dividend Aristocrat?

Is Chemfab Alkalis (NSE:CHEMFAB) Likely To Turn Things Around?

Third quarter 2021 earnings released: EPS ₹0.88 (vs ₹3.98 in 3Q 2020)

Chemfab Alkalis (NSE:CHEMFAB) Has A Somewhat Strained Balance Sheet

New 90-day high: ₹146

Three Things You Should Check Before Buying Chemfab Alkalis Limited (NSE:CHEMFAB) For Its Dividend

What Do The Returns On Capital At Chemfab Alkalis (NSE:CHEMFAB) Tell Us?

New 90-day low: ₹125

Are Chemfab Alkalis's (NSE:CHEMFAB) Statutory Earnings A Good Guide To Its Underlying Profitability?

First half earnings released

New 90-day low: ₹129

Chemfab Alkalis Limited to Report Q2, 2021 Results on Oct 29, 2020

We Think Chemfab Alkalis (NSE:CHEMFAB) Is Taking Some Risk With Its Debt

New 90-day high - ₹153

First quarter earnings released

Here’s What’s Happening With Returns At Chemfab Alkalis (NSE:CHEMFAB)

Is Chemfab Alkalis Limited (NSE:CHEMFAB) A Good Fit For Your Dividend Portfolio?

Chemfab Alkalis Limited to Report Q1, 2021 Results on Jul 30, 2020

Previsiones de crecimiento de beneficios e ingresos